HUMACYTE INC
HUMANASDAQ🏆 #3854 by market capEarnings Nov 11US Equity
$0.47▲ $0.02 (+5.33%)
🌅 Pre-market$0.47▼ 0.02%Regular close · extended-hours price shownTrack HUMA
Get earnings, price moves & breaking news on Telegram
24h▲ 5.3%
7d▲ 12.1%
14d▲ 7.4%
30d▼ 12.4%
ytd▼ 51.1%
1y▼ 72.1%
🏦Market Cap
$131M
Small Cap
📈Revenue Growth (YoY)
231.7%
High Growth
📊Gross Margin
-494.6%
Thin
💵FCF Margin
—
⚖️P/S Ratio
58.5x
Expensive
Otter Score
—
Insufficient data
HUMACYTE INC
HUMAAnalyst Ratings
Price
$0.4701
Total
11
Raised
0
Lowered
0
Avg PT
$1.50
H / L
$2 / $1
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Benchmark | Reiterated | Speculative Buy | 2026-08-13 | — | — |
BTIG | Reiterated | Buy | 2026-07-28 | $2.00 | +325.40% |
TD Cowen | Reiterated | Buy | 2026-06-17 | — | — |
HC Wainwright & Co. | Reiterated | Buy | 2026-06-11 | — | — |
D. Boral Capital | Reiterated | Buy | 2026-04-28 | — | — |
Barclays | Reiterated | Overweight | 2026-04-08 | $3.50 | +644.50% |
Piper Sandler | Reiterated | Neutral | 2026-03-30 | $6.00 | +1176.30% |
EF Hutton | Reiterated | Buy | 2024-10-28 | — | — |
Cantor Fitzgerald | Reiterated | Overweight | 2024-09-20 | — | — |
Cowen & Co. | Reiterated | Outperform | 2021-10-29 | $5.00 | +963.60% |
Oppenheimer | Reiterated | Outperform | 2021-09-24 | — | — |
Institution
Benchmark
Reiterated · Speculative Buy · 2026-08-13
—
—
BTIG
Reiterated · Buy · 2026-07-28
$2.00
+325.40%
TD Cowen
Reiterated · Buy · 2026-06-17
—
—
HC Wainwright & Co.
Reiterated · Buy · 2026-06-11
—
—
D. Boral Capital
Reiterated · Buy · 2026-04-28
—
—
Barclays
Reiterated · Overweight · 2026-04-08
$3.50
+644.50%
Piper Sandler
Reiterated · Neutral · 2026-03-30
$6.00
+1176.30%
EF Hutton
Reiterated · Buy · 2024-10-28
—
—
Cantor Fitzgerald
Reiterated · Overweight · 2024-09-20
—
—
Cowen & Co.
Reiterated · Outperform · 2021-10-29
$5.00
+963.60%
Oppenheimer
Reiterated · Outperform · 2021-09-24
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space